CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate For The MyoPro For Review At The Upcoming HCPCS Public Meeting
Portfolio Pulse from Benzinga Newsdesk
Myomo, Inc. (NYSE:MYO), a wearable medical robotics company, announced that the Centers for Medicare & Medicaid Services (CMS) has posted a proposed Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) fee schedule payment rate for the MyoPro. The proposed rates for the two HCPCS codes describing the MyoPro are $31,745.42 and $62,457.28. The final rule classifying the MyoPro as a brace will enable reimbursement on a lump sum basis from January 1, 2024.
November 06, 2023 | 1:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The proposed fee schedule rates by CMS for Myomo's MyoPro could potentially increase the company's revenues if finalized. However, the company cannot provide any assurance that these rates will be finalized and published in their current amounts, or at all.
The proposed fee schedule rates by CMS for Myomo's MyoPro could potentially increase the company's revenues if finalized. This is because the rates would determine the amount of reimbursement the company would receive for its MyoPro devices. However, the company has stated that it cannot provide any assurance that these rates will be finalized and published in their current amounts, or at all, which introduces a level of uncertainty.
CONFIDENCE 70
IMPORTANCE 80
RELEVANCE 100